Invesco Ltd. Assembly Biosciences, Inc. Transaction History

Invesco Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.46 - $2.45 $65,228 - $109,458	-44,677 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.13 - $3.46 $10,136 - $16,466	-4,759 Reduced 9.63%	44,677 $104,000
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $4,813 - $5,978	1,533 Added 3.2%	49,436 $172,000
Q2 2021 Aug 17, 2021	SELL	$3.8 - $4.56 $26,508 - $31,810	-6,976 Reduced 12.71%	47,903 $186,000
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $180,279 - $276,040	41,635 Added 314.37%	54,879 $253,000
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $64,498 - $228,988	13,244 New	13,244 $80,000
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $131,874 - $236,464	-8,745 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $127,414 - $209,530	8,745 New	8,745 $204,000
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $465,426 - $962,122	-45,319 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $378,866 - $1.08 Million	45,319 New	45,319 $927,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.